Completion requirements
Further Reading (optional)
If you would like to learn more about this topic, we recommend you to visit the following:
- Epigenetics - What is epigenetics?: MedlinePlus Genetics and Epigenetics - Wikipedia
- Proteomics technologies - Molecular Biologist's Guide to Proteomics - PMC (nih.gov) and Proteomics - Wikipedia
- Biomarkers in drug development - Waterton JC, Pylkkanen L. Qualification of imaging biomarkers for oncology drug development. European Journal Cancer 2012:48; 409-415 - Available at: Qualification of imaging biomarkers for oncology drug development (ejcancer.com)
- Principle of the Sanger method of DNA sequencing - Available at: Sanger method of DNA sequencing, 3D animation with narration :: CSHL DNA Learning Center
- EMA Note for guidance on definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. November 2007 - Available at: E15 Definitions for genomic biomarkers, phamacogenomics, pharmacogenetics, genomic data and sample coding categories (europa.eu)
- The International Human Genome Mapping Consortium (2001) A physical map of the human genome Nature 409, 934-941 - Available at: A physical map of the human genome | Nature
- Green EM, Gozani O. Everybody’s welcome: the big tent approach to epigenetic drug discovery. Drug Discovery Today: Therapeutic Strategies. 2012; 9: e75-e81- Available at: Everybody’s welcome: The big tent approach to epigenetic drug discovery - PMC (nih.gov)
- Qualification opinion of low hippocampal volume (atrophy) by MRI for use in regulatory clinical trials - in pre-dementia stage of Alzheimer’s disease - Available at: Qualification opinion of low hippocampal volume (atrophy) by MRI for use in clinical trials for regulatory purpose - in pre-dementia stage of Alzheimer’s disease (europa.eu)
- Fact Sheet on Gene therapy produced by the Centre for Genetics Education (Australia) - Available at: Gene therapy and advanced therapeutics (genetics.edu.au)
- European Medicines Agency stance on stem cell research - Advanced therapy medicinal products: Overview | European Medicines Agency (europa.eu)
- European Medicines Agency Committee for Advanced Therapies (CAT) - Use of unregulated stem-cell based medicinal products - Use of unregulated stem-cell based medicinal products - The Lancet